Top Story

VIDEO: Understanding of genetics in AML, MDS help predict prognosis, response to treatment

May 6, 2016

In this video with Healio.com, Rafael Bejar, MD, PhD, of the University of California, San Diego, discusses advances in understanding the genetics of myeloid malignancies, including acute myeloid leukemia and myelodysplastic syndrome.

In the Journals

Treatment of HCC in patients with hepatitis C cirrhosis is costly

May 6, 2016
The real-world cost of care to treat hepatocellular carcinoma for patients with hepatitis C cirrhosis is very high, according to findings from a retrospective cohort…
Meeting News Coverage

Pediatrician counseling rates regarding sun protection remain low

May 6, 2016
BALTIMORE — Physician counseling about sun protection and indoor tanning among children and adolescents needs to be further improved, according to survey findings…
At Issue

Surge in FDA-approved myeloma agents brings new therapeutic decision challenges

May 6, 2016
With a record number of FDA approvals granted for multiple myeloma drugs in the past year, the field is buoyed by the range of treatment options that stand to enhance…
Meeting News Coverage

Clinically diagnosed tumors linked to improvements in cancer-specific survival

May 6, 2016
A clinical diagnosis of early-stage lung cancer was associated with improvements in cancer-specific survival compared with only receiving a pathological diagnosis…
More News Headlines »

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Meeting News Coverage

VIDEO: Liquid biopsy technology a ‘major advance’ but still requires validation

May 5, 2016
More »
CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today